Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease

被引:7
作者
Nakahara, Hirotomo [1 ,2 ]
Cheedarla, Narayanaiah [2 ]
Verkerke, Hans P. [2 ]
Cheedarla, Suneethamma [2 ]
Wu, Shang-Chuen [3 ]
Hendrickson, Jeanne E. [1 ,2 ,4 ]
Chang, Andres
McLemore, Morgan L.
El Rassi, Fuad
Roback, John D. [1 ,2 ]
Neish, Andrew S. [2 ,5 ]
Fasano, Ross M. [1 ,2 ,5 ,6 ]
Stowell, Sean R. [3 ,5 ]
机构
[1] Emory Univ, Ctr Transfus Med & Cellular Therapies, Sch Med, Atlanta, GA USA
[2] Emory Univ, Dept Pathol & Lab Med, Sch Med, Atlanta, GA USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Joint Program Transfus Med, Boston, MA 02115 USA
[4] Yale Sch Med, Dept Lab Med, New Haven, CT USA
[5] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA USA
[6] Emory Univ, Dept Pathol & Lab Med, Hematol, Sch Med, Atlanta, GA 30322 USA
基金
美国国家卫生研究院;
关键词
antibodies; haemoglobinopathies; immunology; sickle cell anaemia; sickle cell disease; vaccines;
D O I
10.1111/bjh.18899
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with sickle cell disease (SCD) are considered to be immunocompromised, yet data on the antibody response to SARS-CoV-2 vaccination in SCD is limited. We investigated anti-SARS-CoV-2 IgG titres and overall neutralizing activity in 201 adults with SCD and demographically matched non-SCD controls. Unexpectedly, patients with SCD generate a more robust and durable COVID-19 vaccine IgG response compared to matched controls, though the neutralizing activity remained similar across both cohorts. These findings suggest that patients with SCD achieve a similar antibody response following COVID-19 vaccination compared to the general population, with implications for optimal vaccination strategies for patients with SCD.
引用
收藏
页码:937 / 941
页数:5
相关论文
共 15 条
[1]   Innate immune cells, major protagonists of sickle cell disease pathophysiology [J].
Allali, Slimane ;
Maciel, Thiago Trovati ;
Hermine, Olivier ;
de Montalembert, Mariane .
HAEMATOLOGICA, 2020, 105 (02) :273-283
[2]   The Development and Consequences of Red Blood Cell Alloimmunization [J].
Arthur, Connie M. ;
Stowell, Sean R. .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2023, 18 :537-564
[3]   Alteration of lymphocyte phenotype and function in sickle cell anemia: Implications for vaccine responses [J].
Balandya, Emmanuel ;
Reynolds, Teri ;
Obaro, Stephen ;
Makani, Julie .
AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (09) :938-946
[4]   Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia [J].
Chang, Andres ;
Akhtar, Akil ;
Linderman, Susanne L. ;
Lai, Lilin ;
Orellana-Noia, Victor M. ;
Valanparambil, Rajesh ;
Ahmed, Hasan ;
Zarnitsyna, Veronika, I ;
McCook-Veal, Ashley A. ;
Switchenko, Jeffrey M. ;
Koff, Jean L. ;
Blum, Kristie A. ;
Ayers, Amy A. ;
O'Leary, Colin B. ;
Churnetski, Michael C. ;
Sulaiman, Shahana ;
Kives, Melissa ;
Sheng, Preston ;
Davis, Carl W. ;
Nooka, Ajay K. ;
Antia, Rustom ;
Dhodapkar, Madhav, V ;
Suthar, Mehul S. ;
Cohen, Jonathon B. ;
Ahmed, Rafi .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (26) :3020-+
[5]  
Cheedarla N., 2022, PREPRINT, DOI [10.21203/rs.3.rs-1322411/v1, DOI 10.21203/RS.3.RS-1322411/V1]
[6]   COVID19 vaccination in adults with sickle cell disease is not associated with increases in rates of pain crisis [J].
Friedman, Elana ;
Minniti, Caterina ;
Campbell, Sean ;
Curtis, Susanna .
HEMATOLOGY, 2022, 27 (01) :742-744
[7]   Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients [J].
Haggenburg, Sabine ;
Lissenberg-Witte, Birgit, I ;
van Binnendijk, Rob S. ;
den Hartog, Gerco ;
Bhoekhan, Michel S. ;
Haverkate, Nienke J. E. ;
de Rooij, Dennis M. ;
van Meerloo, Johan ;
Cloos, Jacqueline ;
Kootstra, Neeltje A. ;
Wouters, Dorine ;
Weijers, Suzanne S. ;
van Leeuwen, Ester M. M. ;
Bontkes, Hetty J. ;
Tonouh-Aajoud, Saida ;
Heemskerk, Mirjam H. M. ;
Sanders, Rogier W. ;
Roelandse-Koop, Elianne ;
Hofsink, Quincy ;
Groen, Kazimierz ;
Cetinel, Lucia ;
Schellekens, Louis ;
den Hartog, Yvonne M. ;
Toussaint, Belle ;
Kant, Iris M. J. ;
Graas, Thecla ;
de Pater, Emma ;
Dik, Willem A. ;
Engel, Marije D. ;
Pierie, Cheyenne R. N. ;
Janssen, Suzanne R. ;
van Dijkman, Edith ;
Poniman, Meliawati ;
Burger, Judith A. ;
Bouhuijs, Joey H. ;
Smits, Gaby ;
Rots, Nynke Y. ;
Zweegman, Sonja ;
Kater, Arnon P. ;
van Meerten, Tom ;
Mutsaers, Pim G. N. J. ;
van Doesum, Jaap A. ;
Broers, Annoek E. C. ;
van Gils, Marit J. ;
Goorhuis, Abraham ;
Rutten, Caroline E. ;
Hazenberg, Mette D. ;
Nijhof, Inger S. .
BLOOD ADVANCES, 2022, 6 (05) :1537-1546
[8]   COVID-19 vaccination status and disease burden in patients with sickle cell disease [J].
Han, Jin ;
Zhang, Xu ;
Molokie, Robert E. ;
Njoku, Franklin U. ;
Hussain, Faiz A. ;
Farooqui, Marwah ;
Rizvi, Insia ;
Saraf, Santosh L. ;
Gordeuk, Victor R. .
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 199 (04) :E21-E24
[9]   Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature [J].
Hoogenboom, Wouter S. ;
Alamuri, Tharun T. ;
McMahon, Daniel M. ;
Balanchivadze, Nino ;
Dabak, Vrushali ;
Mitchell, William B. ;
Morrone, Kerry B. ;
Manwani, Deepa ;
Duong, Tim Q. .
BLOOD REVIEWS, 2022, 53
[10]   Safety of coronavirus disease 2019 vaccines in 213 adult patients with sickle cell disease [J].
Joseph, Laure ;
Corbasson, Anne ;
Manceau, Sandra ;
Khimoud, Djamal ;
Meunier, Benoit ;
Cheminet, Geoffrey ;
Lefrere, Francois ;
Jannot, Anne-Sophie ;
Lu, Estelle ;
Arlet, Jean-Benoit .
BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (05) :563-567